An economic evaluation of an early palliative care intervention among patients with advanced cancer
BACKGROUND: Early integration of palliative care into oncology care has shown positive effects on patient symptoms and quality of life. It may also reduce health care costs. However given the heterogeneity of settings and interventions and the lack of information on the minimally effective dose for...
Uloženo v:
| Vydáno v: | Swiss medical weekly Ročník 154; číslo 2; s. 3591 |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Switzerland
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
16.02.2024
|
| Témata: | |
| ISSN: | 1424-3997, 1424-3997 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | BACKGROUND: Early integration of palliative care into oncology care has shown positive effects on patient symptoms and quality of life. It may also reduce health care costs. However given the heterogeneity of settings and interventions and the lack of information on the minimally effective dose for influencing care utilisation and costs, it remains uncertain whether early palliative care reduces costs.
OBJECTIVES: We sought to determine whether an early palliative care intervention integrated in usual oncology care in a Swiss hospital setting reduced utilisation and costs of health care in the last month of life when compared with usual oncology care alone.
METHODS: We performed a cost-consequences analysis alongside a multicentre trial. We extracted costs from administrative health insurance data and health care utilisation from family caregiver surveys to compare two study arms: usual oncology care and usual oncology care plus the palliative care intervention. The intervention consisted of a single-structured, multiprofessional conversation with the patient about symptoms, end-of-life decisions, network building and support for carers (SENS). The early palliative care intervention was performed within 16 weeks of the diagnosis of a tumour stage not amenable or responsive to curative treatment.
RESULTS: We included 58 participants with advanced cancer in our economic evaluation study. Median overall health care costs in the last month of life were 7892 Swiss Francs (CHF) (interquartile range: CHF 5637–13,489) in the intervention arm and CHF 8492 [CHF 5411–12,012] in the control arm. The average total intervention treatment cost CHF 380 per patient. Integrating an early palliative care intervention into usual oncology care showed no significant difference in health care utilisation or overall health care costs between intervention and control arms (p = 0.98).
CONCLUSION: Although early palliative care is often presented as a cost-reducing care service, we could not show a significant effect of the SENS intervention on health care utilisation and costs in the last month of life. However, it may be that the intervention was not intensive enough, the timeframe too short or the study population too small for measurable effects. Patients appreciated the intervention. Single-structured early palliative care interventions are easy to implement in clinical practice and present low treatment costs. Further research about the economic impact of early palliative care should focus on extracting large, detailed cost databases showing potential shifts in cost and cost-effectiveness.
Clinical Trials. gov Identifier: NCT01983956 |
|---|---|
| AbstractList | Early integration of palliative care into oncology care has shown positive effects on patient symptoms and quality of life. It may also reduce health care costs. However given the heterogeneity of settings and interventions and the lack of information on the minimally effective dose for influencing care utilisation and costs, it remains uncertain whether early palliative care reduces costs.
We sought to determine whether an early palliative care intervention integrated in usual oncology care in a Swiss hospital setting reduced utilisation and costs of health care in the last month of life when compared with usual oncology care alone.
We performed a cost-consequences analysis alongside a multicentre trial. We extracted costs from administrative health insurance data and health care utilisation from family caregiver surveys to compare two study arms: usual oncology care and usual oncology care plus the palliative care intervention. The intervention consisted of a single-structured, multiprofessional conversation with the patient about symptoms, end-of-life decisions, network building and support for carers (SENS). The early palliative care intervention was performed within 16 weeks of the diagnosis of a tumour stage not amenable or responsive to curative treatment.
We included 58 participants with advanced cancer in our economic evaluation study. Median overall health care costs in the last month of life were 7892 Swiss Francs (CHF) (interquartile range: CHF 5637-13,489) in the intervention arm and CHF 8492 [CHF 5411-12,012] in the control arm. The average total intervention treatment cost CHF 380 per patient. Integrating an early palliative care intervention into usual oncology care showed no significant difference in health care utilisation or overall health care costs between intervention and control arms (p = 0.98).
Although early palliative care is often presented as a cost-reducing care service, we could not show a significant effect of the SENS intervention on health care utilisation and costs in the last month of life. However, it may be that the intervention was not intensive enough, the timeframe too short or the study population too small for measurable effects. Patients appreciated the intervention. Single-structured early palliative care interventions are easy to implement in clinical practice and present low treatment costs. Further research about the economic impact of early palliative care should focus on extracting large, detailed cost databases showing potential shifts in cost and cost-effectiveness.
gov Identifier: NCT01983956. BACKGROUND: Early integration of palliative care into oncology care has shown positive effects on patient symptoms and quality of life. It may also reduce health care costs. However given the heterogeneity of settings and interventions and the lack of information on the minimally effective dose for influencing care utilisation and costs, it remains uncertain whether early palliative care reduces costs. OBJECTIVES: We sought to determine whether an early palliative care intervention integrated in usual oncology care in a Swiss hospital setting reduced utilisation and costs of health care in the last month of life when compared with usual oncology care alone. METHODS: We performed a cost-consequences analysis alongside a multicentre trial. We extracted costs from administrative health insurance data and health care utilisation from family caregiver surveys to compare two study arms: usual oncology care and usual oncology care plus the palliative care intervention. The intervention consisted of a single-structured, multiprofessional conversation with the patient about symptoms, end-of-life decisions, network building and support for carers (SENS). The early palliative care intervention was performed within 16 weeks of the diagnosis of a tumour stage not amenable or responsive to curative treatment. RESULTS: We included 58 participants with advanced cancer in our economic evaluation study. Median overall health care costs in the last month of life were 7892 Swiss Francs (CHF) (interquartile range: CHF 5637–13,489) in the intervention arm and CHF 8492 [CHF 5411–12,012] in the control arm. The average total intervention treatment cost CHF 380 per patient. Integrating an early palliative care intervention into usual oncology care showed no significant difference in health care utilisation or overall health care costs between intervention and control arms (p = 0.98). CONCLUSION: Although early palliative care is often presented as a cost-reducing care service, we could not show a significant effect of the SENS intervention on health care utilisation and costs in the last month of life. However, it may be that the intervention was not intensive enough, the timeframe too short or the study population too small for measurable effects. Patients appreciated the intervention. Single-structured early palliative care interventions are easy to implement in clinical practice and present low treatment costs. Further research about the economic impact of early palliative care should focus on extracting large, detailed cost databases showing potential shifts in cost and cost-effectiveness. Clinical Trials. gov Identifier: NCT01983956 Early integration of palliative care into oncology care has shown positive effects on patient symptoms and quality of life. It may also reduce health care costs. However given the heterogeneity of settings and interventions and the lack of information on the minimally effective dose for influencing care utilisation and costs, it remains uncertain whether early palliative care reduces costs.BACKGROUNDEarly integration of palliative care into oncology care has shown positive effects on patient symptoms and quality of life. It may also reduce health care costs. However given the heterogeneity of settings and interventions and the lack of information on the minimally effective dose for influencing care utilisation and costs, it remains uncertain whether early palliative care reduces costs.We sought to determine whether an early palliative care intervention integrated in usual oncology care in a Swiss hospital setting reduced utilisation and costs of health care in the last month of life when compared with usual oncology care alone.OBJECTIVESWe sought to determine whether an early palliative care intervention integrated in usual oncology care in a Swiss hospital setting reduced utilisation and costs of health care in the last month of life when compared with usual oncology care alone.We performed a cost-consequences analysis alongside a multicentre trial. We extracted costs from administrative health insurance data and health care utilisation from family caregiver surveys to compare two study arms: usual oncology care and usual oncology care plus the palliative care intervention. The intervention consisted of a single-structured, multiprofessional conversation with the patient about symptoms, end-of-life decisions, network building and support for carers (SENS). The early palliative care intervention was performed within 16 weeks of the diagnosis of a tumour stage not amenable or responsive to curative treatment.METHODSWe performed a cost-consequences analysis alongside a multicentre trial. We extracted costs from administrative health insurance data and health care utilisation from family caregiver surveys to compare two study arms: usual oncology care and usual oncology care plus the palliative care intervention. The intervention consisted of a single-structured, multiprofessional conversation with the patient about symptoms, end-of-life decisions, network building and support for carers (SENS). The early palliative care intervention was performed within 16 weeks of the diagnosis of a tumour stage not amenable or responsive to curative treatment.We included 58 participants with advanced cancer in our economic evaluation study. Median overall health care costs in the last month of life were 7892 Swiss Francs (CHF) (interquartile range: CHF 5637-13,489) in the intervention arm and CHF 8492 [CHF 5411-12,012] in the control arm. The average total intervention treatment cost CHF 380 per patient. Integrating an early palliative care intervention into usual oncology care showed no significant difference in health care utilisation or overall health care costs between intervention and control arms (p = 0.98).RESULTSWe included 58 participants with advanced cancer in our economic evaluation study. Median overall health care costs in the last month of life were 7892 Swiss Francs (CHF) (interquartile range: CHF 5637-13,489) in the intervention arm and CHF 8492 [CHF 5411-12,012] in the control arm. The average total intervention treatment cost CHF 380 per patient. Integrating an early palliative care intervention into usual oncology care showed no significant difference in health care utilisation or overall health care costs between intervention and control arms (p = 0.98).Although early palliative care is often presented as a cost-reducing care service, we could not show a significant effect of the SENS intervention on health care utilisation and costs in the last month of life. However, it may be that the intervention was not intensive enough, the timeframe too short or the study population too small for measurable effects. Patients appreciated the intervention. Single-structured early palliative care interventions are easy to implement in clinical practice and present low treatment costs. Further research about the economic impact of early palliative care should focus on extracting large, detailed cost databases showing potential shifts in cost and cost-effectiveness.CONCLUSIONAlthough early palliative care is often presented as a cost-reducing care service, we could not show a significant effect of the SENS intervention on health care utilisation and costs in the last month of life. However, it may be that the intervention was not intensive enough, the timeframe too short or the study population too small for measurable effects. Patients appreciated the intervention. Single-structured early palliative care interventions are easy to implement in clinical practice and present low treatment costs. Further research about the economic impact of early palliative care should focus on extracting large, detailed cost databases showing potential shifts in cost and cost-effectiveness.gov Identifier: NCT01983956.CLINICAL TRIALSgov Identifier: NCT01983956. BACKGROUND: Early integration of palliative care into oncology care has shown positive effects on patient symptoms and quality of life. It may also reduce health care costs. However given the heterogeneity of settings and interventions and the lack of information on the minimally effective dose for influencing care utilisation and costs, it remains uncertain whether early palliative care reduces costs. OBJECTIVES: We sought to determine whether an early palliative care intervention integrated in usual oncology care in a Swiss hospital setting reduced utilisation and costs of health care in the last month of life when compared with usual oncology care alone. METHODS: We performed a cost-consequences analysis alongside a multicentre trial. We extracted costs from administrative health insurance data and health care utilisation from family caregiver surveys to compare two study arms: usual oncology care and usual oncology care plus the palliative care intervention. The intervention consisted of a single-structured, multiprofessional conversation with the patient about symptoms, end-of-life decisions, network building and support for carers (SENS). The early palliative care intervention was performed within 16 weeks of the diagnosis of a tumour stage not amenable or responsive to curative treatment. RESULTS: We included 58 participants with advanced cancer in our economic evaluation study. Median overall health care costs in the last month of life were 7892 Swiss Francs (CHF) (interquartile range: CHF 5637–13,489) in the intervention arm and CHF 8492 [CHF 5411–12,012] in the control arm. The average total intervention treatment cost CHF 380 per patient. Integrating an early palliative care intervention into usual oncology care showed no significant difference in health care utilisation or overall health care costs between intervention and control arms (p = 0.98). CONCLUSION: Although early palliative care is often presented as a cost-reducing care service, we could not show a significant effect of the SENS intervention on health care utilisation and costs in the last month of life. However, it may be that the intervention was not intensive enough, the timeframe too short or the study population too small for measurable effects. Patients appreciated the intervention. Single-structured early palliative care interventions are easy to implement in clinical practice and present low treatment costs. Further research about the economic impact of early palliative care should focus on extracting large, detailed cost databases showing potential shifts in cost and cost-effectiveness. Clinical Trials. gov Identifier: NCT01983956 |
| Author | Aebersold, Daniel M. Maier, Marina Gahl, Brigitta Fliedner, Monica C. Zwahlen, Susanne Eychmüller, Steffen Maessen, Maud |
| Author_xml | – sequence: 1 givenname: Maud surname: Maessen fullname: Maessen, Maud – sequence: 2 givenname: Monica C. surname: Fliedner fullname: Fliedner, Monica C. – sequence: 3 givenname: Brigitta surname: Gahl fullname: Gahl, Brigitta – sequence: 4 givenname: Marina surname: Maier fullname: Maier, Marina – sequence: 5 givenname: Daniel M. surname: Aebersold fullname: Aebersold, Daniel M. – sequence: 6 givenname: Susanne surname: Zwahlen fullname: Zwahlen, Susanne – sequence: 7 givenname: Steffen surname: Eychmüller fullname: Eychmüller, Steffen |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38579309$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkU1LBDEMhosofqziP5De9LLaTjsfPYr4BYIXPZdMm2plpl3b2RX_vXVXxVPCmydvQnJAtkMMSMgxZ-d1y7v2Ip-LWvEtss9lJedCqXb7X75HDnJ-Y6zqGl7vkj3R1a0STO0Tcxkomhji6A3FFQxLmHwMNDoKpQJp-KQLGAZf5BVSAwmpDxOmFYY1CGMMLwWZfBEy_fDTKwW7gmDQFryEdEh2HAwZj37ijDzfXD9d3c0fHm_vry4f5kbIappX4JxqQShjZddz59CIyiKvmeCdYqZiwGXT945LaFjXCu4a3vTQILcMsRMzcr_xtRHe9CL5EdKnjuD1WojpRUOavBlQC46qNSBAOitlK_raCmvRVGDKAMmL19nGa5Hi-xLzpEefDQ4DBIzLrAUrO0v13TsjJz_osh_R_g3-PXIBTjeASTHnhO4P4Uyv36eLYXmf-AI91404 |
| Cites_doi | 10.1177/02692163211005340 10.1016/j.jval.2017.12.006 10.1016/j.jpainsymman.2016.01.009 10.1186/s12904-017-0213-0 10.1097/CCM.0000000000004016 10.1007/s11864-021-00836-1 10.1111/ecc.12453 10.1097/SPC.0000000000000197 10.1200/JCO.2014.60.2334 10.1136/bmj.d1548 10.1177/082585971302900305 10.1089/jpm.2015.0476 10.1007/s00038-020-01428-w 10.1136/bmjspcare-2014-000784 10.1186/s12913-020-05295-2 10.1111/ecc.13198 10.1111/ecc.13620 10.1089/jpm.2015.0119 10.1136/qshc.8.4.219 10.1093/annonc/mdx757 10.1377/hlthaff.2010.0929 10.1200/JCO.2016.70.1474 10.1093/geront/46.4.503 10.1001/jamainternmed.2018.0750 10.1097/MLR.0000000000000634 10.1177/0269216319847884 10.1177/0269216317690098 10.1016/j.jpainsymman.2019.08.026 10.1024/0040-5930/a000256 10.3390/healthcare7010032 |
| ContentType | Journal Article |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 DOA |
| DOI | 10.57187/s.3591 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1424-3997 |
| ExternalDocumentID | oai_doaj_org_article_31e97ca3a4fd4473b5d3ddec2acbbf41 38579309 10_57187_s_3591 |
| Genre | Multicenter Study Journal Article |
| GroupedDBID | --- 123 29Q 2WC 5VS AAFWJ AAYXX ACGFO ADBBV AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS BAWUL BCNDV CITATION DIK E3Z EBS EJD F5P FRP GROUPED_DOAJ GX1 KQ8 OVT P2P RNS TR2 W2D XSB CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c342t-2aff97a39cd48b1ffec32de15031890c20a146bbf14a608731f616ba6e1d0ee83 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 0 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001339233400008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1424-3997 |
| IngestDate | Fri Oct 03 12:46:04 EDT 2025 Thu Jul 10 22:36:11 EDT 2025 Tue Jul 08 01:40:54 EDT 2025 Sat Nov 29 04:17:57 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| License | https://creativecommons.org/licenses/by/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c342t-2aff97a39cd48b1ffec32de15031890c20a146bbf14a608731f616ba6e1d0ee83 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://doaj.org/article/31e97ca3a4fd4473b5d3ddec2acbbf41 |
| PMID | 38579309 |
| PQID | 3034249447 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_31e97ca3a4fd4473b5d3ddec2acbbf41 proquest_miscellaneous_3034249447 pubmed_primary_38579309 crossref_primary_10_57187_s_3591 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-02-16 |
| PublicationDateYYYYMMDD | 2024-02-16 |
| PublicationDate_xml | – month: 02 year: 2024 text: 2024-02-16 day: 16 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Swiss medical weekly |
| PublicationTitleAlternate | Swiss Med Wkly |
| PublicationYear | 2024 |
| Publisher | SMW supporting association (Trägerverein Swiss Medical Weekly SMW) |
| Publisher_xml | – name: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) |
| References | 86428 86429 86426 86427 86424 86425 86422 86444 86423 86445 86420 86442 86421 86443 86440 86441 86419 86417 86439 86418 86415 86437 86416 86438 86413 86435 86414 86436 86433 86412 86434 86431 86432 86430 |
| References_xml | – ident: 86422 doi: 10.1177/02692163211005340 – ident: 86427 doi: 10.1016/j.jval.2017.12.006 – ident: 86432 doi: 10.1016/j.jpainsymman.2016.01.009 – ident: 86412 doi: 10.1186/s12904-017-0213-0 – ident: 86440 – ident: 86419 doi: 10.1097/CCM.0000000000004016 – ident: 86445 – ident: 86415 doi: 10.1007/s11864-021-00836-1 – ident: 86443 doi: 10.1111/ecc.12453 – ident: 86414 doi: 10.1097/SPC.0000000000000197 – ident: 86438 doi: 10.1200/JCO.2014.60.2334 – ident: 86441 doi: 10.1136/bmj.d1548 – ident: 86426 doi: 10.1177/082585971302900305 – ident: 86421 doi: 10.1089/jpm.2015.0476 – ident: 86444 doi: 10.1007/s00038-020-01428-w – ident: 86413 doi: 10.1136/bmjspcare-2014-000784 – ident: 86437 doi: 10.1186/s12913-020-05295-2 – ident: 86433 doi: 10.1111/ecc.13198 – ident: 86416 doi: 10.1111/ecc.13620 – ident: 86435 doi: 10.1089/jpm.2015.0119 – ident: 86428 doi: 10.1136/qshc.8.4.219 – ident: 86418 doi: 10.1093/annonc/mdx757 – ident: 86420 doi: 10.1377/hlthaff.2010.0929 – ident: 86429 – ident: 86417 doi: 10.1200/JCO.2016.70.1474 – ident: 86430 doi: 10.1093/geront/46.4.503 – ident: 86434 doi: 10.1001/jamainternmed.2018.0750 – ident: 86442 doi: 10.1097/MLR.0000000000000634 – ident: 86423 doi: 10.1177/0269216319847884 – ident: 86436 doi: 10.1097/MLR.0000000000000634 – ident: 86439 doi: 10.1177/0269216317690098 – ident: 86431 doi: 10.1016/j.jpainsymman.2019.08.026 – ident: 86424 doi: 10.1024/0040-5930/a000256 – ident: 86425 doi: 10.3390/healthcare7010032 |
| SSID | ssj0028615 |
| Score | 2.364104 |
| Snippet | BACKGROUND: Early integration of palliative care into oncology care has shown positive effects on patient symptoms and quality of life. It may also reduce... Early integration of palliative care into oncology care has shown positive effects on patient symptoms and quality of life. It may also reduce health care... |
| SourceID | doaj proquest pubmed crossref |
| SourceType | Open Website Aggregation Database Index Database |
| StartPage | 3591 |
| SubjectTerms | Behavior Therapy Cost-Benefit Analysis Humans Neoplasms - therapy Palliative Care Quality of Life |
| Title | An economic evaluation of an early palliative care intervention among patients with advanced cancer |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/38579309 https://www.proquest.com/docview/3034249447 https://doaj.org/article/31e97ca3a4fd4473b5d3ddec2acbbf41 |
| Volume | 154 |
| WOSCitedRecordID | wos001339233400008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1424-3997 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0028615 issn: 1424-3997 databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07T8MwELagQogF8aY8KiOxhsax48dYEBUDVAyAukWOH1KXtGpafj_nxC1lQCxMkWJbtr6zz3f2-TuEbo23mrk8TUDX8YQZaxPwQ2TinDeuLCnxTTKYj2cxGsnxWL1upPoKMWEtPXALXJ8Sp4TRVDNvGRO0zC2FJWkybcrSN0_WM7B6Vs5UdLUkbNTtE9kclK_o13c0V-TH3tNQ9P9uVzb7y_AA7UfDEA_aAR2iLVcdod2XePV9jMygwi6-IsbfHN146rGGksBTjGc6HJ4EBYZDRBeebAQ04iatEI48qjUOB7B4FQEA1eEzP0Hvw8e3h6ckZkhIDGXZIsm090poqoxlsiQhAoRm1oGRB0tVpSZLNWhCwIkwzVMpAHpOeKm5IzZ1TtJT1KmmlTtH2HDumdECzEXCSm5kbp2ymluZZj4nogtVInbFrCXCKMCBaOAt6iLA20X3AdN1cWCubn6APIsoz-IveXbRzUoiBcz0cH2hKzddQheBrZApaNRFZ62o1l1RmYOiSdXFfwzhEu1lYLqE2GzCr1BnMV-6a7RjPheTet5D22Ise810-wJ23t4i |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+economic+evaluation+of+an+early+palliative+care+intervention+among+patients+with+advanced+cancer&rft.jtitle=Swiss+medical+weekly&rft.au=Maud+Maessen&rft.au=Monica+C.+Fliedner&rft.au=Brigitta+Gahl&rft.au=Marina+Maier&rft.date=2024-02-16&rft.pub=SMW+supporting+association+%28Tr%C3%A4gerverein+Swiss+Medical+Weekly+SMW%29&rft.eissn=1424-3997&rft.volume=154&rft.issue=2&rft_id=info:doi/10.57187%2Fs.3591&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_31e97ca3a4fd4473b5d3ddec2acbbf41 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1424-3997&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1424-3997&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1424-3997&client=summon |